Kevin M. Brennan

Insider Reports History

Entity
Individual
Location
C/O Xilio Therapeutics, Inc., 828 Winter Street, Waltham, MA
Signature
/s/ Julia Walcott, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kevin M. Brennan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Xilio Therapeutics, Inc. SVP, FINANCE AND ACCOUNTING Restricted Stock Units 20K $205K $10.24 Jan 1, 2024 Direct
Xilio Therapeutics, Inc. SVP, FINANCE AND ACCOUNTING Stock Option (right to buy) 20K May 1, 2024 Direct

Insider Reports Filed by Kevin M. Brennan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
XLO Xilio Therapeutics, Inc. May 1, 2024 1 $0 4 May 3, 2024 SVP, FINANCE AND ACCOUNTING
XLO Xilio Therapeutics, Inc. Jan 1, 2024 1 $0 4 Jan 3, 2024 SVP, FINANCE AND ACCOUNTING
XLO Xilio Therapeutics, Inc. Aug 16, 2023 1 $0 4 Aug 18, 2023 SVP, FINANCE AND ACCOUNTING
XLO Xilio Therapeutics, Inc. Apr 1, 2023 1 $0 4 Apr 3, 2023 SVP, FINANCE AND ACCOUNTING
XLO Xilio Therapeutics, Inc. Mar 30, 2023 0 $0 3 Apr 3, 2023 SVP, FINANCE AND ACCOUNTING